Glaukos (GKOS) Cash from Investing Activities (2014 - 2026)
Glaukos (GKOS) posted quarterly Cash from Investing Activities of -$5.3 million for Q2 2026, up 74.47% year-over-year from -$3.0 million in Q2 2025, and down 150.51% quarter-over-quarter from $10.5 million in Q1 2026.
Glaukos (GKOS) Cash from Investing Activities (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Cash from Investing Activities for 13 consecutive years, with -$5.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Investing Activities rose 74.47% year-over-year to -$5.3 million; the TTM figure through Jun 2026 stood at -$14.7 million (up 4.52% YoY), while the FY2025 annual figure was -$77.6 million, down 262.27% from the prior year.
- Cash from Investing Activities declined to -$5.3 million in Q2 2026 per GKOS's latest filing, from $10.5 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $34.9 million in Q2 2024 and bottomed at -$36.9 million in Q1 2025.
- Historically, Cash from Investing Activities has averaged $1.9 million across 5 years, with a median of $2.8 million in 2022.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities jumped 573.45% — and 2025, when it tumbled 234.81%.
- Glaukos' Cash from Investing Activities stood at $16.7 million in 2022, then sank by 177.58% to -$12.9 million in 2023, then soared by 191.22% to $11.8 million in 2024, then sank by 234.81% to -$15.9 million in 2025, then soared by 66.61% to -$5.3 million in 2026.
- Business Quant data shows GKOS's Cash from Investing Activities at -$5.3 million in Q2 2026, $10.5 million in Q1 2026, and -$15.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Glaukos | 11.03 Bn | 10.92 Bn | 151.59 Mn | -5.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.31 Mn |
| Jun 30, 2026 | -5.31 Mn |
| Mar 31, 2026 | 10.50 Mn |
| Mar 31, 2026 | 10.50 Mn |
| Dec 31, 2025 | -15.89 Mn |
| Dec 31, 2025 | -15.89 Mn |
| Sep 30, 2025 | -3.99 Mn |
| Sep 30, 2025 | -3.99 Mn |
| Jun 30, 2025 | -20.78 Mn |
| Jun 30, 2025 | -20.78 Mn |
| Mar 31, 2025 | -36.95 Mn |
| Mar 31, 2025 | -36.95 Mn |
| Dec 31, 2024 | 11.79 Mn |
| Dec 31, 2024 | 11.79 Mn |
| Sep 30, 2024 | 30.56 Mn |
| Sep 30, 2024 | 30.56 Mn |
| Jun 30, 2024 | 34.86 Mn |
| Jun 30, 2024 | 34.86 Mn |
| Mar 31, 2024 | -29.38 Mn |
| Mar 31, 2024 | -29.38 Mn |